Atrial natriuretic peptide vs. N-terminal-pro-atrial natriuretic peptide for the detection of left atrial dilatation in horses.

This research investigates the effectiveness of two biomarkers, atrial natriuretic peptide (ANP) and N-Terminal proANP (NT-proANP), in detecting left atrial dilation in horses. It concludes that ANP is more suitable than NT-proANP for this detection, despite ANP being less stable when samples are stored at a temperature of -20°C as opposed to -80°C.

About the Research and Biomarkers

• The research focuses on the diagnostic ability of ANP and NT-proANP, two biomarkers, in spotting left atrial dilation in horses, a condition often associated with mitral valve regurgitation.
• Atrial Natriuretic Peptide (ANP) is a hormone released by heart cells in response to high blood pressure. It is often used as a biomarker for cardiovascular conditions, including left atrial dilation.
• NT-proANP, the N-Terminal prohormone of ANP, is a more stable protein than ANP. Its stability suggested it could be a reliable biomarker for clinical use.

Study Design

• The study was a prospective clinical trial involving three groups of horses. Group 1 was made up of healthy horses, Group 2 consisted of horses with mitral valve regurgitation but normal atrial size, and Group 3 included horses suffering from mitral valve regurgitation in conjugation with left atrial dilation.
• Study data was gathered by comparing the concentrations of ANP and NT-proANP in each group. These concentrations were measured using enzyme-linked immunosorbent assays, a common laboratory technique.
• The study also investigated the effect of sample storage temperatures on these biomarkers, comparing measurements taken from samples stored at -80°C and -20°C.

Findings and Implications

• The researchers found that horses in Group 3 (mitral valve regurgitation with left atrial dilation) had a significantly higher concentration of ANP, compared to horses in Groups 1 and 2.
• However, no significant differences were observed in NT-proANP concentrations across the groups.
• Moreover, ANP was found to be less stable than NT-proANP, showing bigger changes in concentration at the two different storage temperatures (-80°C and -20°C).
• Despite ANP’s less stable nature, the researchers concluded it was a better biomarker for detecting left atrial dilation in horses, as it showed measurable differences in concentration among horses with this condition.
• The findings could help improve the diagnostic accuracy for left atrial dilation in horses by suggesting a more appropriate biomarker and understanding of the storage conditions that affect it.